20 participants
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-10-10
- Start Date:
- 2018-10-15
- Completion:
- 2023-03-31
Conditions
- Acute Myeloid Leukemia in Remission
Interventions
- BIOLOGICAL
No Results Yet